InvestorsHub Logo
Followers 105
Posts 2892
Boards Moderated 0
Alias Born 09/16/2011

Re: crossroad post# 21424

Wednesday, 04/25/2012 12:23:16 PM

Wednesday, April 25, 2012 12:23:16 PM

Post# of 80868
You're very welcome, crossroad. I am someone who is passionate about things I believe in, and it is reflected in my posts. I have been an analyst (in one form or another) for most of my professional career, and that too is reflected in my posts. With all my skills, I do not believe that I could have pulled off the extraordinary organizational growth that the MP founders/execs have achieved. I know that being able to raise tremendous funds (some would say limitless) via share sales/convertible debt has lessened the burden, but it still had to be a delicate balancing act. For example, this growth was not simply about money, it was also about developing important relationships in several industries. I look forward to the continued growth of this company, and as a shareholder, expect to eventually participate in their success. As always, simply my opinion.

Thanks, Odessa for all your value-added posts. Based on Q1-12 revenue numbers ($23.5 million sales/qtr, including $4.5 million backlog, or around $100 million a year) Musclepharm is not far from BSN's total revenue $135 million when it was bought out by Glanbia in 2011. I am pretty sure established industry players are aware of this and trying to find ways to stop MP's march. I would not be surprised if they achieve $50 million in sales/qtr by the end of this year. Given the insane revenue growth of MP, there is no way you can value this company at less than a quarter billion dollar right now (I would say half a billion dollar is more appropriate given their phenomenal market penetration). We are lucky to find a gem like MP, which has the potential to be the next Underarmour. It is a lifetime opportunity, IMO. Having said that, financing this tremendous growth would be a huge challenge for them. I read numerous posts on this board regarding the possibility of future dilution. IMO, MP has past the stage of raising money through dilution. As they have registered their first profit, they should be able to get a credit line from a scheduled bank margined against accounts receivables and inventory at a rate cheaper than that on their existing debt. However, all this has not yet been reflected on their sp. I think market is slowly absorbing all the recent news and waiting for confirmation from MP regarding share structure, corporate governance, business and financing plans. This market inefficiency is short-term (a few days or weeks), IMO, and cannot persist in the long-run. I was thinking about start unloading my position once the sp reaches 5 cents, but after they released their Q1-12 preliminary results, I have changed by mind and plan to hold all the shares until they get bought our or listed on a higher exchange. It is so much fun to experience Musclepharm taking over the supplement world and our wealth grow so quickly (in the end, market will come to terms and MP share will reflect its true value). I believe this stock could change my life! Thanks everyone for their valuable inputs. Go MSLP!!


MSLP